A new class of tight binding non-nucleoside reverse transcriptase inhibitors inhibit the burst and steady-state phases of wild-type and Y188L HIV-1 reverse transcriptase activity

被引:0
|
作者
Leveque, V. [1 ]
Giannetti, Tony [1 ]
Li, Y. [1 ]
Deval, J. [1 ]
Harris, S. [1 ]
Cammack, N. [1 ]
Klumpp, K. [1 ]
机构
[1] Roche Palo Alto LLC, Palo Alto, CA 94304 USA
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:A58 / A58
页数:1
相关论文
共 50 条
  • [41] Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors
    Harrigan, PR
    Mo, T
    Wynhoven, B
    Hirsch, J
    Brumme, Z
    McKenna, P
    Pattery, T
    Vingerhoets, J
    Bacheler, LT
    AIDS, 2005, 19 (06) : 549 - 554
  • [42] Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains
    Barreca, Maria Letizia
    Rao, Angela
    De Luca, Laura
    Iraci, Nunzio
    Monforte, Anna-Maria
    Maga, Giovanni
    De Clercq, Erik
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) : 1956 - 1960
  • [43] The role of nucleic acid in the resistance of HIV-1 reverse transcriptase to nucleoside and non-nucleoside inhibitors
    Arnold, E
    Das, K
    Ding, JP
    Hsiou, Y
    Tantillo, C
    Roy, BM
    Yadav, P
    Zhang, WY
    Lentz, K
    Clark, AD
    Boyer, PL
    Hughes, SH
    Mitsuya, H
    Mellors, J
    Kleim, JP
    Rosner, M
    Moereels, HR
    Koymans, L
    Andries, K
    Pauwels, R
    Janssen, PAJ
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 7 - 7
  • [44] Q145M, a novel HIV-1 reverse transcriptase mutation conferring resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors
    Paolucci, S
    Baldanti, F
    Tinelli, M
    Labo, N
    Cattaneo, E
    Maga, G
    Gerna, G
    ANTIVIRAL THERAPY, 2002, 7 : S46 - S46
  • [45] Synthesis and biological activity of new pyridone diaryl ether non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Kennedy-Smith, Joshua J.
    Arora, Nidhi
    Billedeau, J. Roland
    Fretland, Jennifer
    Hang, Julie Q.
    Heilek, Gabrielle M.
    Harris, Seth F.
    Hirschfeld, Donald
    Javanbakht, Hassan
    Li, Yu
    Liang, Weiling
    Roetz, Ralf
    Smith, Mark
    Su, Guoping
    Suh, Judy M.
    Villasenor, Armando G.
    Wu, Jeffrey
    Yasuda, Dennis
    Klumpp, Klaus
    Sweeney, Zachary K.
    MEDCHEMCOMM, 2010, 1 (01) : 79 - 83
  • [46] HIV-1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS - STRUCTURAL BASED DRUG DESIGN
    Ziolkowska, N. E.
    Bujacz, G. D.
    Michejda, C. J.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C124 - C124
  • [47] Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
    Schauer, Grant
    Leuba, Sanford
    Sluis-Cremer, Nicolas
    BIOMOLECULES, 2013, 3 (04): : 889 - 904
  • [48] Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
    Pribut, Nicole
    Basson, Adriaan E.
    van Otterlo, Willem A. L.
    Liotta, Dennis C.
    Pelly, Stephen C.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (02): : 196 - 202
  • [49] Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
    Wang, Yali
    De Clercq, Erik
    Li, Guangdi
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (10) : 813 - 829
  • [50] Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
    De Clercq, E
    FARMACO, 1999, 54 (1-2): : 26 - 45